̽»¨Ö±²¥

Meet Daniel Ives, co-founder of a Cambridge start-up with one big ambition: to put an end to ageing and the diseases that come with it. 

Dr Giorgia Longobardi, founder and CEO of ̽»¨Ö±²¥ spinout Cambridge GaN Devices, is harnessing the extraordinary properties of superconductor gallium nitride to halve the amount of energy we use to power our increasingly digital lives.

Med-tech start-up has raised £1 million in its first round of funding to help it develop the NeutroCheck, a fully-integrated clinical, AI and medical device-based system for people living with cancer.  

RegGenome, a commercial spin-out from the ̽»¨Ö±²¥ of Cambridge, has announced the completion of a $6 million seed funding round.

Marcel Gehrung, co-founder and CEO of rapidly growing Cambridge biotech company, Cyted, on revolutionising disease diagnostics and the challenges of building a business during a pandemic.  

'Enterprising mind', David Cleevely, one of the architects of Cambridge's world-leading innovation ecosystem, on the secrets of entrepreneurial success and why Cambridge is a great place to start a new venture. 

Meet the young biotech entrepreneur with two companies to her name and a plan to revolutionise the way we manage our health.

Cambridge spin-out Zetta Genomics has raised £2.5 million in new seed funding from Nina Capital, APEX Medical and Cambridge Enterprise to advance its genomic data management technology and power the discovery and delivery of precision medicine at scale.

Pro-Vice-Chancellor for Enterprise and Business Relations, Professor Andy Neely, on why universities need to work with business partners, the challenges of doing so and the satisfaction of making things happen.

Meet social enterprise founder, Francesca O'Hanlon whose tech start-up is partnering with local plumbing businesses to bring clean water to communities in Uganda.